Healthcare
Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.
Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum
-
11 Apr 2024  |  North America
Global Blood Group Typing Industry, Forecast to 2028
Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities
This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anem...
$4,950.00 -
09 Apr 2024  |  North America
US and European Home Care Digitalization Growth Opportunities Forecast to 2028
Technology will Support Consumer Preferences for Receiving Care in the Comfort of Home
Home has become an attractive care delivery site because of the convenience, affordability, and patient-centric care environment it offers. The home care digitalization industry represents technologies that home care agencies use to improve/enhance services for the end user (B2B2C). The industry picked up pace during the COVID-19 pandemic and has s...
$4,950.00 -
09 Apr 2024  |  North America
Growth Opportunities in the Oral Solid Dosage Formulation Industry
Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential
This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It...
$2,450.00 -
09 Apr 2024  |  North America
Growth Opportunities in Global Biotech Investment, 2024
Big Biopharma Companies Disruptive Technologies and Portfolio Realignment Will Ensure the Growth Potential of Biotech Investments
In this analysis, Frost & Sullivan provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage. To understand the trend outlook fo...
$2,450.00 -
09 Apr 2024  |  North America
Global Medtech Outlook, 2024
New Product Development and Approvals Drive Industry Growth Opportunities
The Global MedTech Outlook, 2024 presents a comprehensive analysis of the global MedTech industry in terms of growth potential and important market dynamics. The analysis covers major MedTech segments such as cardiovascular, orthopedics, patient monitoring, respiratory devices, neurology, diabetes care, and clinical-grade wearables. It highlights k...
$4,950.00 -
04 Apr 2024  |  North America
Global Heart Valves Industry Forecast to 2028
Investments in Innovative Technologies Enable Growth Opportunities
In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry. Our analysis shows that the industry is gaining traction...
$4,950.00 -
01 Mar 2024  |  North America
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00 -
20 Feb 2024  |  North America
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00 -
19 Feb 2024  |  Global
Innovations in Small Molecule Drug Delivery and Formulation
Disruptive Technologies Drive Growth Opportunities for New Product Launches
Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...
$4,950.00 -
31 Jan 2024  |  North America
Digital Health Regulations in North America and Europe: Growth Opportunities 2023
Innovative Business Models and Technologies are Leading to the Introduction of Disruptive Regulations
This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...
$2,450.00